US patent granted

We finally achieved a US patent, covering the galangal granulate which we use in Punalpin and Punalpin PLUS. The granulate is characterized by a high content of the active compound acetoxychavicol acetate (ACA) and a long shelf life. The application was submitted to the US patent authority (USPTO) back in 2014, so it’s been a […]

Nerthus wins Award!

On the 2nd and 3rd of September, Nerthus participated in European Food Venture Forum in Aarhus. Together with 7 other innovative, European food companies Nerthus won an award for the project with the most potential. Altogether 32 European food companies had been selected for the competition. The award gives access to a final competition in Düsseldorf later this […]

EFSA opinion published

In July 2014 we submitted a health claim application to the European Food Safety Authority (EFSA) and the EU Commission regarding the physiological effect of the two ingredients in Punalpin® (pomegranate and galangal). The purpose with this application was to achieve the right to claim the ingredients in Punalpin, i.e. to tell the customers, which […]

Results of clinical study published in international scientific journal

Punalpin differs from many other dietary supplements in that it was actually tested in a clinical study before marketing. The clinical study is of high standard (a so-called randomized, doubleblinded, placebo-controlled study) and includes 66 study participants. The positive result of the study has now been published in the international, peer-reviewed journal Plos One.

Health claim application submitted to EFSA

In July we submitted an application to EFSA (the European Food Safety Authority) regarding the authorization of a health claim on our combination of pomegranate extract and galangal rhizome. In other words, we apply for permission to tell about the physiological effect of our specific combination of pomegranate extract and galangal rhizome. In the EU […]